Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis.
Haizhu ChenYu FengYu ZhouYunxia TaoLe TangYuan-Kai ShiPublished in: Cancer immunology, immunotherapy : CII (2022)
ICIs may be clinically active in NSCLC patients with BMs. More effective treatments for BMs from NSCLC are needed.